Pediatric sepsis in the developing world

Niranjan Kissoon1, Jonathan Carapetis2

  • 1Global Child Health, Department of Pediatrics and Emergency Medicine, University of British Columbia, Vancouver V6H 3V4, Canada.

Insights

Sepsis is the leading cause of child mortality globally, yet it is often overlooked in global death estimates. Recognizing sepsis as the common endpoint of severe infections is crucial for improving care, especially in resource-limited settings.

Area of Science:

  • Global Health
  • Pediatric Infectious Diseases
  • Critical Care Medicine

Background:

  • Sepsis is the primary cause of death in children worldwide.
  • Current global mortality estimates often fail to highlight sepsis as the unifying cause of death from various severe infections.
  • Underestimating sepsis impacts the focus and effectiveness of interventions, particularly in resource-limited areas.

Purpose of the Study:

  • To emphasize the critical role of sepsis in global child mortality.
  • To advocate for the recognition of sepsis as a distinct and unifying cause of death.
  • To highlight the importance of sepsis management in resource-limited healthcare settings.

Main Methods:

  • The study reviews global mortality data and emphasizes the common pathway of sepsis in deaths attributed to specific infections.
  • It analyzes the implications of classifying deaths by specific causes versus recognizing the underlying sepsis.
  • The authors discuss the practical challenges and potential benefits of focusing on sepsis in low-resource environments.

Main Results:

  • Sepsis is identified as the leading, yet often underreported, cause of pediatric mortality globally.
  • Classifying deaths solely by primary infection (e.g., pneumonia, malaria) obscures the common critical endpoint of sepsis.
  • Focusing on sepsis and essential interventions can improve care delivery by less specialized healthcare teams.

Conclusions:

  • Recognizing and prioritizing sepsis in global child mortality statistics is essential for accurate assessment and targeted interventions.
  • Highlighting sepsis as the end result of severe infections is critical for improving clinical practice and outcomes, especially in resource-limited settings.
  • Simple, emergency therapeutic interventions for sepsis can be effectively implemented by healthcare providers with limited training, improving survival rates in vulnerable populations.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
389
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
499
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
829
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
354
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
727
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
886